HomeBUSINESS
BUSINESS

Shionogi Loses HIV Patent Battle against MSD
(Sep.10.2018)

The Intellectual Property High Court of Japan has slapped down Shionogi’s claims that the anti-HIV medicine Isentress (raltegravir) being marketed by MSD infringes its patent related to integrase inhibitors, the Japanese company said ...
(LOG IN FOR FULL STORY)

News Calendar